Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Almirall develops new Janus kinase inhibitors

June 25, 2012

Spanish group presents novel immunomodulators

June 25, 2012

Novel S1P1 receptor modulators reported by Allergan

June 25, 2012

Merck Serono patents new GM-CSF-directed immunotherapies

June 25, 2012

Danish company divulges novel CaS receptor agonists

June 25, 2012

IRM and Novartis team up to design novel FGF-21 variants

June 22, 2012

Collaborating organizations design new GM-CSF-targeting products

June 22, 2012

New GPR119 receptor agonists patented by Pfizer

June 22, 2012

Lupin presents novel candidate diabetes therapies

June 22, 2012

Novel diagnostics for cancer disclosed by French team

June 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...